Agenus Inc. Made Headway
Fri 29 May 20 at 05:30 PM
Agenus Inc. (AGEN:NASDAQ) jumped higher at $3.73, representing a gain of 29.5%. On Thu 28 May 20, AGEN:NASDAQ hit a New 2-Week High of $2.88. The stock appeared on our News Catalysts scanner on Thu 28 May 20 at 11:20 AM in the 'BIOTECH' category. From Thu 14 May 20, the stock recorded 66.67% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Agenus Inc. (AGEN:NASDAQ)
Agenus Inc along with its subsidiaries is a pharmaceutical company. It is engaged in discovery and development of revolutionary new treatments that engage the body's immune system to benefit patients suffering from cancer.
Top 10 Gainers:
- Adaptimmune Therapeutics plc (ADAP:NASDAQ), 127.78%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 79.3%
- AgeX Therapeutics, Inc. (AGE:NYSEMKT), 49.67%
- Pacific Ethanol, Inc. (PEIX:NASDAQ), 36.82%
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 36.16%
- Millendo Therapeutics, Inc. (MLND:NASDAQ), 34.34%
- Nabriva Therapeutics plc (NBRV:NASDAQ), 33.91%
- Allied Esports Entertainment Inc. (AESE:NASDAQ), 33.88%
- Digital Ally, Inc. (DGLY:NASDAQ), 33.35%
- Agenus Inc. (AGEN:NASDAQ), 29.51%